Tudor Investment Corp Acquires $13.5M Stake in Bio-Techne

The hedge fund now owns 0.16% of the biotechnology company's shares.

Apr. 6, 2026 at 11:28am

Got story updates? Submit your updates here. ›

Tudor Investment Corp ET AL, a hedge fund, bought a new stake of 242,016 shares in Bio-Techne Corp (NASDAQ:TECH) during the third quarter, according to a recent SEC filing. The stake is valued at approximately $13.5 million, making Tudor Investment Corp ET AL a 0.16% owner of the biotechnology company.

Why it matters

This investment by a major hedge fund signals confidence in Bio-Techne's growth potential within the biotechnology sector. Tudor Investment Corp ET AL's stake acquisition could also indicate broader institutional interest in the company.

The details

According to the SEC filing, Tudor Investment Corp ET AL purchased the 242,016 shares of Bio-Techne in the third quarter. This represents approximately 0.16% ownership of the biotechnology company. Other hedge funds have also recently bought and sold shares of Bio-Techne, suggesting increased institutional activity around the stock.

  • The stake was acquired during the third quarter of the year.
  • The SEC filing disclosing the transaction was made on April 6, 2026.

The players

Tudor Investment Corp ET AL

A hedge fund that has acquired a $13.5 million stake in Bio-Techne, representing 0.16% ownership of the biotechnology company.

Bio-Techne Corp

A global life sciences company that develops, manufactures, and sells high-quality reagents, instruments, and services for the research, diagnostic, and bioprocessing markets.

Got photos? Submit your photos here. ›

The takeaway

This investment by a prominent hedge fund highlights the growing institutional interest in Bio-Techne, a leading player in the biotechnology industry. The stake acquisition could signal broader confidence in the company's growth prospects and future performance.